•
ZV
ZVRA
Zevra Therapeutics, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
508.37M
Volume
1.34M
52W High
$13.16
52W Low
$6.19
Open
$0.00
Prev Close
$9.03
Day Range
0.00 - 0.00
About Zevra Therapeutics, Inc. Common Stock
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Latest News
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•Oct 6
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
Benzinga•Feb 27
Zevra Therapeutics Announces Organizational Changes
GlobeNewswire Inc.•Dec 6
Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFAâ„¢ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
GlobeNewswire Inc.•Nov 21
Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
GlobeNewswire Inc.•Nov 11
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
GlobeNewswire Inc.•Aug 2
Zevra Therapeutics Expands Executive Leadership Team
GlobeNewswire Inc.•Jun 25
Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders
GlobeNewswire Inc.•Jun 18